Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended				161 Months Ended
	Mar. 31, 2013		Mar. 31, 2012		Mar. 31, 2013
NET REVENUES
Sales	$ 3,140		$ 3,740		$ 464,295
Royalties			10,000		645,180
TOTAL NET REVENUE	3,140		13,740		1,109,475
COST OF SALES	2,710		2,036		431,741
GROSS PROFIT	430		11,704		677,734
OPERATING EXPENSES
General and administrative	98,309		26,690		1,641,668
Legal and accounting	112,437		90,347		1,651,223
Patent costs					65,000
Payroll expenses	536,329	[1]	45,000	[1]	3,949,311	[1]
Research and development	149,156		1,257		1,016,948
Sales and marketing	52,304		12,308		5,072,036
Total operating expenses	948,535		175,602		13,396,186
LOSS BEFORE OTHER INCOME	(948,105)		(163,898)		(12,718,452)
OTHER INCOME (EXPENSE)
Interest income					63,664
Interest expense	(41,241)		(71,707)		(2,231,673)
Change in fair value of warrants	(11,921,510)				(11,921,510)
Fair value of warrants in excess of consideration for convertible preferred stock	(2,995,791)				(2,995,791)
Gain on debt forgiveness			0		340,352
Gain on disposition of assets			0		4,722
TOTAL OTHER INCOME (EXPENSE)	(14,958,542)		(71,707)		(16,740,236)
LOSS BEFORE INCOME TAX BENEFIT	(15,906,647)		(235,605)		(29,458,688)
INCOME TAX BENEFIT					(165,000)
NET LOSS	(15,906,647)		(235,605)		(29,293,688)
Less: Deemed dividend distribution	(1,000,000)				(1,000,000)
NET LOSS APPLICABLE TO COMMON STOCKHOLDERS	$ (16,906,647)		$ (235,605)		$ (30,293,688)
BASIC AND DILUTED NET LOSS PER COMMON SHARE (in dollars per share)	$ (0.07)		$ 0.00
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING (in shares)	227,124,683		145,144,603

[1] includes share based compensation of $1,048,121 cumulative, $332,599 for the three months ended March 31, 2013 and $0 for the three months ended March 31, 2012.